title: Role of protein phosphatases in regulation of cardiac inotropy and relaxation.
abstract: We studied the effects of the protein phosphatase (PP) inhibitor cantharidin (Cant) on time parameters and force of contraction (FOC) in isometrically contracting electrically driven guinea pig papillary muscles. We correlated the mechanical parameters of contractility with phosphorylation of the inhibitory subunit of troponin (TnI-P) and with the site-specific phosphorylation of phospholamban (PLB) at serine-16 (PLB-Ser-16) and threonine-17 (PLB-Thr-17). Cant (after 30 min) started to increase FOC (112 +/- 4% of control, n = 10) and TnI-P and PLB-Thr-17 (120 +/- 5 and 128 +/- 7% of control) without any alteration of relaxation time. Cant (10 microM) started to increase PLB-Ser-16, but the relaxation was shortened at only 100 microM (from 140 +/- 9 to 116 +/- 12 ms, n = 9). Moreover, 100 microM Cant, 3 min after application, started to increase PLB-Thr-17, TnI-P, and FOC. Cant (100 microM) began to increase PLB-Ser-16 after 20 min. This was accompanied by shortening of relaxation time. Differences in protein kinase activation or different substrate specificities of PP may explain the difference in Cant-induced site-specific phosphorylation of PLB in isometrically contracting papillary muscles. Moreover, PLB-Thr-17 may be important for inotropy, whereas PLB-Ser-16 could be a major determinant of relaxation time.
authors.affiliation: Institut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität Münster, D-48129 Münster, Germany. boknik@uni-muenster.de
authors.forename: P
authors.initials: P
authors.lastname: Bokník
authors.forename: S
authors.initials: S
authors.lastname: Khorchidi
authors.forename: G S
authors.initials: GS
authors.lastname: Bodor
authors.forename: S
authors.initials: S
authors.lastname: Huke
authors.forename: J
authors.initials: J
authors.lastname: Knapp
authors.forename: B
authors.initials: B
authors.lastname: Linck
authors.forename: H
authors.initials: H
authors.lastname: Lüss
authors.forename: F U
authors.initials: FU
authors.lastname: Müller
authors.forename: W
authors.initials: W
authors.lastname: Schmitz
authors.forename: J
authors.initials: J
authors.lastname: Neumann
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002118:Calcium / Q000032:analysis; D002135:Calcium-Binding Proteins / Q000378:metabolism; D002193:Cantharidin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D018485:Muscle Fibers, Skeletal / Q000201:enzymology; D009200:Myocardial Contraction / Q000502:physiology*; D009206:Myocardium / Q000166:cytology / Q000201:enzymology*; D010210:Papillary Muscles / Q000166:cytology / Q000201:enzymology; D010477:Perfusion; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism*; D010766:Phosphorylation; D051381:Rats; D014336:Troponin / Q000378:metabolism; D000099211:Phospholamban
chemical_list: D000906:Antibodies; D002118:Calcium; D002135:Calcium-Binding Proteins; D002193:Cantharidin; D004791:Enzyme Inhibitors; D010749:Phosphoprotein Phosphatases; D014336:Troponin; D000099211:Phospholamban